ALC vs BIIB
Alcon Inc vs Biogen — AI-powered side-by-side comparison
| Metric | ALC | BIIB |
|---|
| AI Score |
68
|
67
|
| Price |
$71.78
|
$208.02
|
| P/E Ratio |
43.26×
|
36.61×
|
| ROE |
4.4%
|
7.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
54.9%
|
67.7%
|
| Debt / Equity |
0.24×
|
0.44×
|
| Dividend Yield |
0.5%
|
0.0%
|
| RSI (14) |
66.2
|
56.7
|
| Beta |
0.703
|
0.158
|
| Expected Upside |
+14.1%
|
+5.2%
|
AI Committee View
Current Innellis committee reasoning for ALC versus BIIB.
ALC leads by 1 points.
ALC scores 68/100 (Buy) versus BIIB at 67/100 (Buy).
ALC Committee View
75% agreement
4 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- No news coverage in the last 14 days -- limited independent confirmation either way — News
BIIB Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.42 across 47 articles, 14d). The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth